Rospatch Corp said itrejected a proposal by Diagnostic Retrieval Systems Inc toacquire its stock at 22 dlrs a share.    Rospatch's board believes that the long term interests ofits shareholders will be best served by continuing as anindependent public company at this time, the company said inresponse to an unsolicited offer from Diagnostic Retrieval.    Rospatch said Diagnostic's offer of February 27 is avariation of a previous offer in January, the nature of whichwas not disclosed.    Rospatch said it advised Diagnostic Retrieval that "itwould be contrary to the best interests of the corporationto engage in any discussions concerning a business combinationwith Diagnostic Retrieval." Reuter&#3;